HEAT BIOLOGICS INC (HTBX) Forecast, Price Target & Analyst Ratings

NYSEARCA:HTBXUS42237K4094

Current stock price

2.38
+0.01 (+0.42%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEAT BIOLOGICS INC (HTBX).

Forecast Snapshot

Consensus Price Target

Price Target
$11.60
+ 387.50% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 17, 2022
Period
Q1 / 2022
EPS Estimate
-$0.50
Revenue Estimate
408K

ChartMill Buy Consensus

Rating
82.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.60
Upside
+ 387.50%
From current price of $2.38 to mean target of $11.60, Based on 10 analyst forecasts
Low
$8.08
Median
$11.22
High
$16.28

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for HTBX. The average price target is 11.6 null. This implies a price increase of 387.5% is expected in the next year compared to the current price of 2.38.

Analyst Ratings & History

Current Analyst Ratings

HTBX Current Analyst RatingHTBX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

HTBX Historical Analyst RatingsHTBX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.00%
HTBX was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about HTBX.
In the previous month the buy percentage consensus was at a similar level.
HTBX was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-03-03Cantor FitzgeraldInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 17, 2022
Period
Q1 / 2022
EPS Estimate
-$0.50
Revenue Estimate
408K
Revenue Q2Q
-24.44%
EPS Q2Q
-62.87%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

HTBX is expected to report earnings on 5/17/2022. The consensus EPS estimate for the next earnings is -0.5 null and the consensus revenue estimate is 408.00K null.

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
HTBX revenue by date.HTBX revenue by date.
3.05M
-47.32%
2.95M
-3.28%
2.113M
-28.38%
4.522M
114.03%
4.76M
5.26%
23.868M
401.43%
58.5M
145.10%
146.25M
150.00%
EBITDA
YoY % growth
HTBX ebitda by date.HTBX ebitda by date.
-19.78M
-11.63%
-25.79M
-30.38%
-33.359M
-29.35%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
HTBX ebit by date.HTBX ebit by date.
-20.01M
-11.41%
-26.12M
-30.53%
-33.967M
-30.04%
N/AN/AN/AN/AN/A
Operating Margin
HTBX operating margin by date.HTBX operating margin by date.
-656.07%-885.42%-1,607.66%N/AN/AN/AN/AN/A
EPS
YoY % growth
HTBX eps by date.HTBX eps by date.
N/A
49.79%
-1.56
63.59%
-1.41
9.62%
-1.74
-23.70%
-1.50
13.84%
-0.93
37.90%
-1.15
-23.40%
-1.45
-25.87%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth
-0.50
-62.87%
-0.48
-86.35%
-0.50
-66.60%
-0.48
11.22%
Revenue
Q2Q % growth
408K
-24.44%
1.428M
210.78%
1.428M
184.71%
2.499M
307.60%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
N/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HTBX Yearly Revenue VS EstimatesHTBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
HTBX Yearly EPS VS EstimatesHTBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.19%
EPS Next 5 Year
-0.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
129.35%
Revenue Next 5 Year
136.46%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

HEAT BIOLOGICS INC / HTBX Forecast FAQ

What is the average price target for HEAT BIOLOGICS INC (HTBX) stock?

10 analysts have analysed HTBX and the average price target is 11.6 null. This implies a price increase of 387.5% is expected in the next year compared to the current price of 2.38.

What is the next earnings date for HTBX stock?

HEAT BIOLOGICS INC (HTBX) will report earnings on 2022-05-17, before the market open.

What are the consensus estimates for HEAT BIOLOGICS INC (HTBX) next earnings?

The consensus EPS estimate for the next earnings of HEAT BIOLOGICS INC (HTBX) is -0.5 null and the consensus revenue estimate is 408.00K null.

How many analysts cover HEAT BIOLOGICS INC (HTBX) stock?

The number of analysts covering HEAT BIOLOGICS INC (HTBX) is 10.